Stockcalc – Free Trial
Have a free look inside the StockCalc website at www.stockcalc.com
I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/TopPicks.aspx.
Undervalued Stocks on AMEX
Today we are looking at companies that are considered undervalued based on the Analyst data in the StockCalc database.
In the table below we can see the close price and target price for these companies along with the number of analysts covering the stock. We also have included the fiscal year for the target price as sometimes these analyst targets are not for the current or even the next fiscal year.
There can be a number of reasons why a company would be on this list. What is particularly interesting are companies with a large analyst following that make this list. We need to dig deeper into these companies to understand why the difference in price versus target.
Today’s Data on AMEX
Today’s data is for companies listed on the American Stock Exchange.
| Symbol | Name | Target Year | Close Price | Target Price Mean | Currency | Target Price # of Estimates |
|---|---|---|---|---|---|---|
| CQP | Cheniere Energy Partners LP | 2017 | 28.480000 | 34.5000 | USD | 2 |
| LNG | Cheniere Energy Inc | 2017 | 42.570000 | 51.0000 | USD | 1 |
| NG | Novagold Resources Inc | 2018 | 4.070000 | 9.0000 | CAD | 1 |
| TXMD | TherapeuticsMD Inc | 2017 | 5.780000 | 17.6667 | USD | 3 |
| MAG | MAG Silver Corp | 2017 | 12.880000 | 24.8486 | CAD | 8 |
| REI | Ring Energy Inc | 2017 | 13.210000 | 20.0000 | USD | 2 |
| ALO | Alio Gold Inc | 2017 | 4.050000 | 9.1682 | CAD | 11 |
| OCX | OncoCyte Corp | 2017 | 4.950000 | 12.0000 | USD | 1 |
| SNMP | Sanchez Midstream Partners LP | 2017 | 10.700000 | 16.0000 | USD | 2 |
| AST | Asterias Biotherapeutics Inc | 2017 | 3.300000 | 12.0000 | USD | 1 |
| DLA | Delta Apparel Inc | 2018 | 19.730000 | 24.0000 | USD | 1 |
| BGSF | BG Staffing Inc | 2017 | 15.230000 | 20.4000 | USD | 2 |
| MTNB | Matinas BioPharma Holdings Inc | 2017 | 1.430000 | 7.6667 | USD | 3 |
| USAS | Americas Silver Corp | 2017 | 3.070000 | 11.1500 | CAD | 1 |
| UUUU | Energy Fuels Inc | 2017 | 1.670000 | 6.0693 | CAD | 1 |
| TIS | Orchids Paper Products Co | 2017 | 10.010000 | 22.0000 | USD | 1 |
| GDP | Goodrich Petroleum Corp | 2017 | 9.360000 | 23.0000 | USD | 1 |
| UFAB | Unique Fabricating Inc | 2017 | 7.770000 | 12.0000 | USD | 2 |
| PLX | Protalix BioTherapeutics Inc | 2017 | 0.575000 | 5.0000 | USD | 1 |
| PLG | Platinum Group Metals Ltd | 2018 | 0.550000 | 5.0000 | CAD | 1 |
| VNRX | VolitionRX Ltd | 2017 | 2.900000 | 8.5000 | USD | 2 |
| VISI | Volt Information Sciences Inc | 2018 | 3.100000 | 8.0000 | USD | 1 |
| RNN | Rexahn Pharmaceuticals Inc | 2017 | 1.980000 | 19.5000 | USD | 2 |
| ATNM | Actinium Pharmaceuticals Inc | 2017 | 0.612300 | 8.0000 | USD | 1 |
| JOB | GEE Group Inc | 2018 | 4.730000 | 10.0000 | USD | 1 |
Let’s look at a few companies…
Lets look at a couple of the companies on this list to get a better understanding of them.
ALO:ASE Alio Gold
http://www.aliogold.com
Alio Gold has 283 employees and is headquartered in Canada.
Alio Gold Inc is a gold mining company. It is engaged in exploration, development and production in Mexico. Its projects include San Francisco mine in Sonora, Mexico and the development stage Ana Paula project in Guerrero, Mexico.
OCX:ASE OncoCyte
http://www.oncocyte.com
OncoCyte has 16 employees and is headquartered in United States.
OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer.
Free Valuation
Run a valuation on any of the companies listed above at www.stockcalc.com/valureport.aspx or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.
The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.